Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis

References

• Benjamin RS. Osteosarcoma: better treatment through better trial design. Lancet Oncol. 2015;16(1 ):12–13. doi:10.1016/S1470-2045(14)71186-625638539
   PubMed Web of Science ®Google Scholar
• Heymann D. Metastatic osteosarcoma challenged by regorafenib. Lancet Oncol. 2019;20(1 ):12–14. doi:10.1016/S1470-2045(18)30821-030477938
   PubMed Web of Science ®Google Scholar
• Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1 ):39–50. doi:10.1080/14737140.2018.141393929210294
   PubMed Web of Science ®Google Scholar
• Friebele JC, Peck J, Pan X, Abdel-Rasoul M, Mayerson JL. Osteosarcoma: a meta-analysis and review of the literature. Am J Orthop. 2015;44(12 ):547–553.26665241
   PubMedGoogle Scholar
• Dubowitz JA, Sloan EK, Riedel BJ. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clin Exp Metastasis. 2018;35(4 ):347–358. doi:10.1007/s10585-017-9862-x28894976
   PubMed Web of Science ®Google Scholar
• Ghoneim AA, Azer MS, Ghobrial HZ, El Beltagy MA. Awakening properties of isoflurane, sevoflurane, and desflurane in pediatric patients after craniotomy for supratentorial tumours. J Neurosurg Anesthesiol. 2015;27(1 ):1–6. doi:10.1097/ANA.000000000000005824633212
   PubMed Web of Science ®Google Scholar
• Jiao B, Yang C, Huang NN, Yang N, Wei J, Xu H. Relationship between volatile anesthetics and tumor progression: unveiling the mystery. Curr Med Sci. 2018;38(6 ):962–967. doi:10.1007/s11596-018-1970-630536056
   PubMed Web of Science ®Google Scholar
• Kim HC, Hong WP, Lim YJ, Park HP. The effect of sevoflurane versus desflurane on postoperative catheter-related bladder discomfort in patients undergoing transurethral excision of a bladder tumour: a randomized controlled trial. Can J Anaesth. 2016;63(5 ):596–602. doi:10.1007/s12630-016-0600-726830645
   PubMed Web of Science ®Google Scholar
• Yang Y, Hu R, Yan J, et al. Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxiainducible factor-1alpha signaling pathway in vitro. Int J Mol Med. 2018;41(2 ):995–1002. doi:10.3892/ijmm.2017.330629207062
   PubMed Web of Science ®Google Scholar
• Gao C, Shen J, Meng ZX, He XF. Sevoflurane inhibits glioma cells proliferation and metastasis through miRNA-124-3p/ROCK1 axis. Pathol Oncol Res. 2019. doi:10.1007/s12253-019-00597-1
   Web of Science ®Google Scholar
• Muller-Edenborn B, Roth-Z’graggen B, Bartnicka K, et al. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology. 2012;117(2 ):293–301. doi:10.1097/ALN.0b013e3182605df122739763
   PubMed Web of Science ®Google Scholar
• Gao K, Su Z, Liu H, Liu Y. Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells. Exp Mol Pathol. 2019;108:121–130. doi:10.1016/j.yexmp.2019.04.00530974101
   PubMed Web of Science ®Google Scholar
• Palmini G, Marini F, Brandi ML. What is new in the miRNA world regarding osteosarcoma and chondrosarcoma? Molecules. 2017;22(3 ):417. doi:10.3390/molecules22030417
   PubMed Web of Science ®Google Scholar
• Sasaki R, Osaki M, Okada F. MicroRNA-based diagnosis and treatment of metastatic human osteosarcoma. Cancers. 2019;11(4 ):553. doi:10.3390/cancers11040553
   PubMed Web of Science ®Google Scholar
• Yi W, Li D, Guo Y, Zhang Y, Huang B, Li X. Sevoflurane inhibits the migration and invasion of glioma cells by upregulating microRNA-637. Int J Mol Med. 2016;38(6 ):1857–1863. doi:10.3892/ijmm.2016.279727840895
   PubMed Web of Science ®Google Scholar
• Fan L, Wu Y, Wang J, He J, Han X. Sevoflurane inhibits the migration and invasion of colorectal cancer cells through regulating ERK/MMP-9 pathway by up-regulating miR-203. Eur J Pharmacol. 2019;850:43–52. doi:10.1016/j.ejphar.2019.01.02530685432
   PubMed Web of Science ®Google Scholar
• Liu J, Yang L, Guo X, et al. Sevoflurane suppresses proliferation by upregulating microRNA-203 in breast cancer cells. Mol Med Rep. 2018;18(1 ):455–460. doi:10.3892/mmr.2018.894929750301
   PubMed Web of Science ®Google Scholar
• Zhou W, Hao M, Du X, Chen K, Wang G, Yang J. Advances in targeted therapy for osteosarcoma. Discov Med. 2014;17(96 ):301–307.24979249
   PubMed Web of Science ®Google Scholar
• Soltanizadeh S, Degett TH, Gogenur I. Outcomes of cancer surgery after inhalational and intravenous anesthesia: a systematic review. J Clin Anesth. 2017;42:19–25. doi:10.1016/j.jclinane.2017.08.00128797751
   PubMed Web of Science ®Google Scholar
• Ding J, Zhang L, Zeng S, Feng T. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways. Biochem Biophys Res Commun. 2019;514:1179–1184. doi:10.1016/j.bbrc.2019.05.08231103261
   PubMed Web of Science ®Google Scholar
• Wang L, Wang T, Gu JQ, Su HB. Volatile anesthetic sevoflurane suppresses lung cancer cells and miRNA interference in lung cancer cells. Onco Targets Ther. 2018;11:5689–5693. doi:10.2147/OTT.S17167230254461
   PubMed Web of Science ®Google Scholar
• Hurmath FK, Mittal M, Ramaswamy P, Umamaheswara Rao GS, Dalavaikodihalli Nanjaiah N. Sevoflurane and thiopental preconditioning attenuates the migration and activity of MMP-2 in U87MG glioma cells. Neurochem Int. 2016;94:32–38. doi:10.1016/j.neuint.2016.02.00326875426
   PubMed Web of Science ®Google Scholar
• Liang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1alpha. J Anesth. 2015;29(6 ):821–830. doi:10.1007/s00540-015-2035-726002230
   PubMed Web of Science ®Google Scholar
• Chen X, Chen XG, Hu X, et al. MiR-34a and miR-203 inhibit survivin expression to control cell proliferation and survival in human osteosarcoma cells. J Cancer. 2016;7(9 ):1057–1065. doi:10.7150/jca.1506127326248
   PubMed Web of Science ®Google Scholar
• Lin W, Zhu X, Yang S, et al. MicroRNA-203 inhibits proliferation and invasion, and promotes apoptosis of osteosarcoma cells by targeting Runt-related transcription factor 2. Biomed Pharmacother. 2017;91:1075–1084. doi:10.1016/j.biopha.2017.05.03428525948
   PubMed Web of Science ®Google Scholar
• Liu S, Feng P. MiR-203 determines poor outcome and suppresses tumor growth by targeting TBK1 in osteosarcoma. Cell Physiol Biochem. 2015;37(5 ):1956–1966. doi:10.1159/00043855626584294
   PubMedGoogle Scholar
• Yang D, Liu G, Wang K. miR-203 acts as a tumor suppressor gene in osteosarcoma by regulating RAB22A. PLoS One. 2015;10(9 ):e0132225. doi:10.1371/journal.pone.013222526382657
   PubMed Web of Science ®Google Scholar
• Ruan X, Jiang W, Cheng P, et al. Volatile anesthetics sevoflurane targets leukemia stem/progenitor cells via Wnt/beta-catenin inhibition. Biomed Pharmacother. 2018;107:1294–1301. doi:10.1016/j.biopha.2018.08.06330257344
   PubMed Web of Science ®Google Scholar
• Hu N, Wang C, Zheng Y, et al. The role of the Wnt/beta-catenin-Annexin A1 pathway in the process of sevoflurane-induced cognitive dysfunction. J Neurochem. 2016;137(2 ):240–252. doi:10.1111/jnc.1356926851642
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Xing Q, et al. Sevoflurane anesthesia in pregnant rats negatively affects nerve function in offspring potentially via inhibition of the Wnt/beta-catenin pathway. Mol Med Rep. 2017;15(5 ):2753–2759. doi:10.3892/mmr.2017.631628447764
   PubMed Web of Science ®Google Scholar